Capabilities by Region: United States
Greenhill has considerable advisory experience in the United States. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a vast network of corporate relationships throughout United States.
Greenhill established its presence in the United States in January 1996 with the opening of our office in New York. Greenhill further expanded its U.S. presence with the opening of Chicago and San Francisco offices in 2008 and the Houston office in 2009.
For more information on Greenhill’s advisory practice in the United States and our capabilities in the region, please contact Chief Executive Officer Scott Bok or President Kevin Costantino in our New York office.
Below we highlight a few of the transactions on which we have advised in this region:
Recent Transactions
Sort By
Brigit
Advised Upbound Group, a technology and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, on its acquisition of Brigit, a leading financial health technology company
Heartland Generation
Strategic advisor to Heartland Generation, one of Alberta's largest power generators and an Energy Capital Partners affiliate, on its sale to TransAlta Corporation
Empire Today
Advised Empire Today, the largest and only national DTC provider of replacement hard surface flooring and carpet in the U.S., on its liability management transaction
Blue Owl Technology Finance Corp. II (“OTF II”)
Advised and provided a fairness opinion to the Special Committee of the Independent Directors of OTF II, a specialty finance company focused on originating and making loans to, and making debt and equity investment in, technology related companies, specifically software, based primarily in the US, on its merger with OTF
Centogene GmbH
Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of pharmaceutical solutions and diagnostic tests for rare diseases